Patents by Inventor Vijaykumar Bhagwan Deore

Vijaykumar Bhagwan Deore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereof
    Patent number: 10273230
    Abstract: The present invention relates to substituted phenyl alkanoic acid compounds designated as the compound of Formula (I) (as described herein) or a tautomer, a stereoisomer, a geometrical isomer, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a prodrug, a polymorph, an N-oxide, a S-oxide or a carboxylic acid isostere thereof; which are GPR120 agonists. The present invention also relates to a pharmaceutical composition of compound of Formula (I) for the treatment of diseases or disorder mediated by GPR120.
    Type: Grant
    Filed: July 23, 2015
    Date of Patent: April 30, 2019
    Assignee: Piramal Enterprises Limited
    Inventors: Sanjay Kumar, Rajiv Sharma, Vijaykumar Bhagwan Deore, Nilambari Nilkanth Yewalkar
  • Compounds for use as GPR120 agonists
    Patent number: 10227360
    Abstract: The present invention relates to a compound of formula (I), or a tautomer, stereoisomer, geometrical isomer, prodrug, carboxylic acid isostere, solvate, polymorph, N-oxide, S-oxide or pharmaceutically acceptable salt thereof, which are GPR120 agonists. The present invention also relates to a pharmaceutical composition of a compound of formula (I) for the treatment of metabolic disorders, particularly Type 2 diabetes and associated diseases.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: March 12, 2019
    Assignee: Piramal Enterprises Limited
    Inventors: Sanjay Kumar, Rajiv Sharma, Somnath Halder, Sangameshwar Prabhakar Sawargave, Vijaykumar Bhagwan Deore
  • SUBSTITUTED PHENYL ALKANOIC ACID COMPOUNDS AS GPR120 AGONISTS AND USES THEREOF
    Publication number: 20170210731
    Abstract: The present invention relates to substituted phenyl alkanoic acid compounds designated as the compound of Formula (I) (as described herein) or a tautomer, a stereoisomer, a geometrical isomer, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a prodrug, a polymorph, an N-oxide, a S-oxide or a carboxylic acid isostere thereof; which are GPR120 agonists. The present invention also relates to a pharmaceutical composition of compound of Formula (I) for the treatment of diseases or disorder mediated by GPR120.
    Type: Application
    Filed: July 23, 2015
    Publication date: July 27, 2017
    Applicant: Piramal Enterprises Limited
    Inventors: Sanjay KUMAR, Rajiv SHARMA, Vijaykumar Bhagwan DEORE, Nilambari Nilkanth YEWALKAR
  • COMPOUNDS FOR USE AS GPR120 AGONISTS
    Publication number: 20160347768
    Abstract: The present invention relates to a compound of formula (I), or a tautomer, stereoisomer, geometrical isomer, prodrug, carboxylic acid isostere, solvate, polymorph, N-oxide, S-oxide or pharmaceutically acceptable salt thereof, which are GPR120 agonists. The present invention also relates to a pharmaceutical composition of a compound of formula (I) for the treatment of metabolic disorders, particularly Type 2 diabetes and associated diseases.
    Type: Application
    Filed: February 18, 2015
    Publication date: December 1, 2016
    Applicant: PIRAMAL ENTERPRISES LIMITED
    Inventors: Sanjay KUMAR, Rajiv SHARMA, Somnath HALDER, Sangameshwar Prabhakar SAWARGAVE, Vijaykumar Bhagwan DEORE
  • Substituted Imidazoquinoline Derivatives
    Publication number: 20130310374
    Abstract: The present invention relates to substituted imidazo[4,5-c]quinoline derivatives of formula (I), wherein R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions comprising compounds of the present invention and their use in the treatment of diseases or disorders mediated by one or more kinases, particularly proliferative diseases or disorders such as cancer. These compounds can also be used in the treatment of inflammation and angiogenesis related disorders.
    Type: Application
    Filed: December 5, 2011
    Publication date: November 21, 2013
    Applicant: PIRAMAL ENTERPRISES LIMITED`
    Inventors: Sanjay Kumar, Rajiv Sharma, Vijaykumar Bhagwan Deore, Nilambari Nilkanth Yewalkar, Veena R. Agarwal, Nilesh Dagia, Nishigandha Naik